An interventional study of rapid prototyping and computed tomography in Tetralogy of Fallot, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 1 Month to 20 Years. Per ClinicalTrials.gov, last updated 2005-12-20.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Diagnostic
Using biocardiac model in helping the total correction of the Tetralogy of Fallot.
Using biocardiac model in helping the total correction of the Tetralogy of Fallot.
93 studies on the registry are indexed under Tetralogy of Fallot; 26 are open to participants now.
This study's enrollment of 50 is close to the median of 51 across 52 interventional studies indexed under Tetralogy of Fallot.
Browse Tetralogy of Fallot studies →National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Tetralogy of Fallot
diagnostic accuracy
sensitivity
specificity
This study is status unknown, as verified in May 2005. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital